GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Assets | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr | ₹3,012 Cr |
What is the latest Total Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹3,967 Cr |
| Mar2024 | ₹3,410 Cr |
| Mar2023 | ₹3,193 Cr |
| Mar2022 | ₹4,520 Cr |
| Mar2021 | ₹3,012 Cr |
How is Total Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,967 Cr | 16.33 | |
| Mar2024 | ₹3,410 Cr | 6.80 | |
| Mar2023 | ₹3,193 Cr | -29.36 | |
| Mar2022 | ₹4,520 Cr | 50.09 | |
| Mar2021 | ₹3,012 Cr | - | |
Compare Total Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,822.9 Cr | 3.4% | -3.3% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.4% |
-3.3% |
-12.5% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses